stars 1 stars 2 stars 3

View Sifarma's top competitors like Boehringer Ingelheim, EDITORIAL SALVAT - Grupo Hachette Livre, and Farmasierra.

Boehringer Ingelheim
Our people are our strength. And together with over 54,000 colleagues, we're creating the next breakthrough in the world of healthcare and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint
Ingelheim am Rhein, DE
Private
$14.1B Revenue
http://www.boehringer-ingelheim.com
47.6K Employees
Pierre Fabre Group
💊🔬 Laboratoires Pierre Fabre is theworld’ssecond-largest dermo-cosmetics company and one ofEurope’sleading pharmaceuticallaboratories. ItsDermo-cosmetics & Personal Careportfolio brings together major international brands such as EauThermaleAvène,Dexeryl,Ducray,Klorane,A-Derma, RenéFurterer,MêmeCosmetics,Darrow, andElgydium. The Pharma activity covers5main therapeutic fields: oncology, dermatology,rare diseases,primarycareand family health care. In 2025, Laboratoires Pierre Fabre generated €3.2 billion euros in revenue, 71% of which came from international sales across 130 territories. Based in southwest France since its creation and manufacturingnearly90%of its products in France, Laboratoires Pierre Fabre employs 10,000 people worldwide. R&D investments increased by 14% compared with the previous year, reaching €250 million, 67% of which is dedicated to targeted therapies in oncology. The majority shareholder of Laboratoires Pierre Fabre is the Pierre Fabre Foundation (holding 86.3% of the capital), a humanitarian foundation recognized as being of public utility. The company’s employees are its second-largest shareholder (nearly 10%). This shareholding structure guarantees the company’s independence, its long-term vision and its sustainable contribution to the common good. Dividends paid to the Pierre Fabre Foundation contribute to 43 healthcare-access projects deployed in 25 of the least developed countries in the world. Since 2022, Laboratoires Pierre Fabre’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development).
Toulouse, FR
Private
$300M Revenue
https://www.pierre-fabre.com
9.8K Employees
Octapharma
Family-owned since 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. We develop and manufacture medicines based on proteins derived from human plasma and human cell lines. More than 11,000 employees worldwide support the treatment of patients in 120 countries. Our products focus on three therapeutic areas: Critical Care, Haematology and Immunotherapy. Octapharma operates seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, as well as over 200 plasma donation centres across Europe and the US. Our community guidelines: https://www.octapharma.com/octapharma/social-media-community-guidelines
Lachen, CH
Private
$2.7B Revenue
http://www.octapharma.com
3K Employees
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users